Cdc6 contributes to cisplatin-resistance by activation of ATR-Chk1 pathway in bladder cancer cells.
Chen S, Chen X, Xie G, He Y, Yan D, Zheng D, Li S, Fu X, Li Y, Pang X, Hu Z, Li H, Tan W, Li J.
Chen S, et al. Among authors: he y.
Oncotarget. 2016 Jun 28;7(26):40362-40376. doi: 10.18632/oncotarget.9616.
Oncotarget. 2016.
PMID: 27246979
Free PMC article.